Insider Trading Activity Immunomedics, Inc. (NASDAQ:IMMU) – Director Sold 40,000 shares of Stock

ME Staff
-
0

Insider Trading Activity For Immunomedics, Inc. (NASDAQ:IMMU)

Cynthia L. Goldenberg , Director of Immunomedics, Inc. (NASDAQ:IMMU) reportedly Sold 40,000 shares of the company’s stock at an average price of 10.72 for a total transaction amount of $428,800.00 SEC Form

Insider Trading History For Immunomedics, Inc. (NASDAQ:IMMU)

  • On 9/13/2013 Don Stark, Director, sold 10,000 with an average share price of $6.08 per share and the total transaction amounting to $60,800.00.View SEC Filing
  • On 12/9/2014 Don C Stark, Director, sold 5,500 with an average share price of $4.51 per share and the total transaction amounting to $24,805.00.View SEC Filing
  • On 12/11/2014 Mary E Paetzold, Director, sold 10,000 with an average share price of $4.71 per share and the total transaction amounting to $47,100.00.View SEC Filing
  • On 6/5/2015 Don C Stark, Director, sold 5,732 with an average share price of $4.14 per share and the total transaction amounting to $23,730.48.View SEC Filing
  • On 6/9/2015 Mary E Paetzold, Director, sold 4,677 with an average share price of $4.60 per share and the total transaction amounting to $21,514.20.View SEC Filing
  • On 6/12/2015 David M Goldenberg, Chairman, sold 359,653 with an average share price of $4.32 per share and the total transaction amounting to $1,553,700.96.View SEC Filing
  • On 6/12/2015 Brian A Markison, Director, sold 5,564 with an average share price of $4.22 per share and the total transaction amounting to $23,480.08.View SEC Filing

    • Analyst Ratings For Immunomedics, Inc. (NASDAQ:IMMU)
    These are 3 Buy Ratings .
    The current consensus rating for Immunomedics, Inc. (NASDAQ:IMMU) is Buy (Score: 3.00) with a consensus target price of $13.00 , a potential (9.80% upside)

    Analyst Ratings History For Immunomedics, Inc. (NASDAQ:IMMU)

    • On 5/5/2017 Wells Fargo & Company Upgraded rating Market Perform to Outperform
    • On 7/24/2017 Cowen and Company Reiterated Rating Outperform with a price target of $15.00
    • On 8/17/2017 Jefferies Group LLC Set Price Target of rating Buy with a price target of $11.00

    Recent Trading Activity for Immunomedics, Inc. (NASDAQ:IMMU)
    Shares of Immunomedics, Inc. closed the previous trading session at 11.84 up +1.46 14.07% with 6,627,060 shares trading hands.